Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Induction of demyelination by intraneural injection of antibodies against sulfoglucuronyl paragloboside.

Maeda Y, Bigbee JW, Maeda R, Miyatani N, Kalb RG, Yu RK.

Exp Neurol. 1991 Aug;113(2):221-5.

PMID:
1868905
2.

Generation and characterization of anti-sulfoglucuronosyl paragloboside monoclonal antibody NGR50 and its immunoreactivity with peripheral nerve.

Yamawaki M, Ariga T, Bigbee JW, Ozawa H, Kawashima I, Tai T, Kanda T, Yu RK.

J Neurosci Res. 1996 Jun 15;44(6):586-93.

PMID:
8794950
3.

Preliminary studies on sensitization of Lewis rats with sulfated glucuronyl paragloboside.

Maeda Y, Brosnan CF, Miyatani N, Yu RK.

Brain Res. 1991 Feb 15;541(2):257-64.

PMID:
1711398
4.

Sensitization of Lewis rats with sulfoglucuronosyl paragloboside: electrophysiological and immunological studies of an animal model of peripheral neuropathy.

Yamawaki M, Vasquez A, Ben Younes A, Yoshino H, Kanda T, Ariga T, Baumann N, Yu RK.

J Neurosci Res. 1996 Apr 1;44(1):58-65.

PMID:
8926631
6.

Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system.

Quarles RH, Ilyas AA, Willison HJ.

Chem Phys Lipids. 1986 Dec 15;42(1-3):235-48. Review.

PMID:
2435424
7.

Generation and characterization of antibodies to sulfated glucuronyl glycolipids in Lewis rats.

Ilyas AA, Chen ZW, Prineas JW.

J Neuroimmunol. 2002 Jun;127(1-2):54-8.

PMID:
12044975
8.

Loss of sulfoglucuronyl and other neolactoglycolipids in Purkinje cell abnormality murine mutants.

Chou DK, Flores S, Jungalwala FB.

J Neurochem. 1990 May;54(5):1589-97.

PMID:
1691279
9.

Immune-mediated demyelination--immunopathological basis for electrophysiological changes.

Saida T, Saida K.

Electroencephalogr Clin Neurophysiol Suppl. 1982;36:56-69.

PMID:
6962042
10.
11.
12.

Cytomegalovirus is not associated with IgM anti-myelin-associated glycoprotein/sulphate-3-glucuronyl paragloboside antibody-associated neuropathy.

Lunn MP, Muir P, Brown LJ, MacMahon EM, Gregson NA, Hughes RA.

Ann Neurol. 1999 Aug;46(2):267-70.

PMID:
10443896
13.

Regulation of sulfoglucuronyl glycolipid synthesis in the developing rat sciatic nerve.

Chou DK, Jungalwala FB.

Neurochem Res. 2001 Nov;26(11):1231-5.

PMID:
11874205
14.

Myelin sheath remodelling in remyelinated rat sciatic nerve.

Hildebrand C.

J Neurocytol. 1989 Jun;18(3):285-94.

PMID:
2746301
15.

Demyelination and axonal degeneration in Lewis rat experimental allergic neuritis depend on the myelin dosage.

Hahn AF, Feasby TE, Steele A, Lovgren DS, Berry J.

Lab Invest. 1988 Jul;59(1):115-25.

PMID:
3260639
16.

Sulfate incorporation into peripheral nerve endoneurial glycolipids after crush and permanent transection injury.

Kohriyama T, Yu RK, Berg CT, Poduslo JF.

J Neurosci Res. 1990 Jun;26(2):144-8.

PMID:
2366259
18.

Tellurium-induced neuropathy: metabolic alterations associated with demyelination and remyelination in rat sciatic nerve.

Harry GJ, Goodrum JF, Bouldin TW, Wagner-Recio M, Toews AD, Morell P.

J Neurochem. 1989 Mar;52(3):938-45.

PMID:
2918316
19.

Antibodies to L-periaxin in sera of patients with peripheral neuropathy produce experimental sensory nerve conduction deficits.

Lawlor MW, Richards MP, De Vries GH, Fisher MA, Stubbs EB Jr.

J Neurochem. 2002 Nov;83(3):592-600.

20.

Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.

Garces-Sanchez M, Dyck PJ, Kyle RA, Zeldenrust S, Wu Y, Ladha SS, Klein CJ.

Muscle Nerve. 2008 Apr;37(4):490-5. doi: 10.1002/mus.20955.

PMID:
18236455

Supplemental Content

Support Center